CNP analogTherapeutic Peptides
Vosoritide (Voxzogo)
A 39-amino acid analog of C-type natriuretic peptide. FDA-approved (2021) for achondroplasia in children 5+. Stimulates endochondral bone growth by counteracting FGFR3 signaling at the growth plate.
bone-growthachondroplasiaCNP-analogFDA-approvedpediatric
3D Structure
3D Structure
4418.09 Da
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A 39-amino acid analog of C-type natriuretic peptide. FDA-approved (2021) for achondroplasia in children 5+. Stimulates endochondral bone growth by counteracting FGFR3 signaling at the growth plate.